AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers

AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.